Literature DB >> 16210495

Increased levels of macrophage migration inhibitory factor in sera of patients with Escherichia coli O157:H7-induced enterocolitis.

Tatsuya Ohkawara, Hiroshi Takeda, Masahiro Asaka, Yuka Mizue, Jun Nishihira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16210495      PMCID： PMC1247830          DOI： 10.1128/CDLI.12.10.1257-1258.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  10 in total

1.  Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome.

Authors:  F Proulx; E Seidman; M M Mariscalco; K Lee; S Caroll
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection.

Authors:  D Karpman; H Connell; M Svensson; F Scheutz; P Alm; C Svanborg
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

4.  Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes.

Authors:  Y Mizue; J Nishihira; T Miyazaki; S Fujiwara; M Chida; K Nakamura; K Kikuchi; M Mukai
Journal:  Int J Mol Med       Date:  2000-04       Impact factor: 4.101

5.  Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis.

Authors:  L E Lehmann; U Novender; S Schroeder; T Pietsch; T von Spiegel; C Putensen; A Hoeft; F Stüber
Journal:  Intensive Care Med       Date:  2001-08       Impact factor: 17.440

6.  Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.

Authors:  Tatsuya Ohkawara; Jun Nishihira; Hiroshi Takeda; Shuhei Hige; Mototsugu Kato; Toshiro Sugiyama; Toshihiko Iwanaga; Hideki Nakamura; Yuka Mizue; Masahiro Asaka
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

7.  Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.

Authors:  F Proulx; J P Turgeon; C Litalien; M M Mariscalco; P Robitaille; E Seidman
Journal:  Pediatr Infect Dis J       Date:  1998-10       Impact factor: 2.129

8.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

Review 9.  Identification of MIF as a new pituitary hormone and macrophage cytokine and its role in endotoxic shock.

Authors:  R Bucala
Journal:  Immunol Lett       Date:  1994-12       Impact factor: 3.685

10.  Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.

Authors:  M Bozza; A R Satoskar; G Lin; B Lu; A A Humbles; C Gerard; J R David
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.